Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles

Journal of Virology

Volumn 75, Issue 14, 2001, Pages 6279-6291

  Day, C L ^a   Shea, A K ^a   Altfeld, M A ^a   Olson, D P ^a   Buchbinder, S P ^a   Hecht, F M ^a   Rosenberg, E S ^a   Walker, B D ^a   Kalams, S A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 1; HLA B7 ANTIGEN; INDINAVIR; LAMIVUDINE; NELFINAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ALLELE; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; HLA TYPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL;

ALLELES; CHRONIC DISEASE; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034984145     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.14.6279-6291.2001     Document Type: Article

References (62)

1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
2. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes
3. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
4. Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition
5. + T-cell responses cannot be predicted by major histocompatibility complex class I haplotype
6. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type I infection
7. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
8. The evolving field of HIV CTL epitope mapping: New approaches to the identification of novel epitopes
9. The HLA class I restricted CTL response in HIV infection: Systematic identification of optimal epitopes
10. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
11. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences
12. The HLA-class I restricted CTL response in HIV-1 infection: Identification of optimal epitopes
13. Comprehensive, serologically equivalent DNA typing for HLA-B by PCR using sequence-specific primers (PCR-SSP)
14. gag protein
15. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
16. + T cells in the central region of the HIV-1 NEF protein
17. Identification of multi-restricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef protein
18. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein
19. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein
20. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
21. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays
22. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
23. Combined structural and immunological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes
24. Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA) - Identical siblings with HLA-A*0201 are influenced by epitope mutation
25. Differential narrow focusing of immunodominant human immunodeficiency virus Gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children
26. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART)
27. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
28. Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease
29. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor
30. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex
31. + T cell depletion in simian immunodeficiency virus-infected macaques
32. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine
33. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: Definition of minimum epitopes and analysis of the effects of sequence variation
34. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells
35. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
36. T cell receptor usage and tine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant
37. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein
38. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
39. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase
40. + CTL clones is limited by elimination due to encounter with HIV-infected targets
41. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides
42. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
43. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
44. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
45. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
46. An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism
47. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: Recognition of autologous virus sequences within a conserved immunodominant epitope
48. + lymphocytes
49. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes
50. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
51. Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1
52. Multi-epitope DNA vaccines
53. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides
54. + cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein
55. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes
56. Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: Implications for vaccine development
57. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1
58. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein
59. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1
60. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: The Ariel Project for the prevention of transmission of HIV from mother to infant
61. + cells in human immunodeficiency virus type I pathogenesis: Cytolytic and noncytolytic inhibition of viral replication
62. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses